Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Scuffham

Showing results (11-20 of 208) with videos related to

Pageof 21
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|May 1, 2009
Pharmacoeconomic benefits of dasatinib in the treatment of imatinib-resistant patients with chronic myelogenous leukemiaMatthew J Taylor, Paul A Scuffham
Pharmacoeconomics|February 26, 2018
The Australian Managed Entry Scheme: Are We Getting it Right?Haitham W Tuffaha, Paul A Scuffham
International Journal of Technology Assessment in Health Care|March 5, 2024
The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancerSrinivas Teppala, Paul A Scuffham, Haitham Tuffaha
Australian Health Review : a Publication of the Australian Hospital Association|September 25, 2018
Simulation of health care and related costs in people with dementia in AustraliaLachlan Standfield, Tracy Comans, Paul A Scuffham
The Lancet. Infectious Diseases|November 11, 2008
Funding of drugs: do vaccines warrant a different approach?Philippe Beutels, Paul A Scuffham, C Raina MacIntyre
Maternal and Child Health Journal|March 16, 2016
Contactable Non-responders Show Different Characteristics Compared to Lost to Follow-Up Participants: Insights from an Australian Longitudinal Birth Cohort StudyShu-Kay Ng, Rani Scott, Paul A Scuffham
The Medical Journal of Australia|February 3, 2017
Setting Medical Research Future Fund priorities: assessing the value of researchHaitham W Tuffaha, Lazaros Andronis, Paul A Scuffham
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Comment on the use of vignettes and the EQ-5D to value disease-specific health statesSanjeewa Kularatna, Jennifer A Whitty, Paul A Scuffham
BMC Health Services Research|May 23, 2008
An economic analysis of email-based telemedicine: a cost minimisation study of two service modelsLiam Caffery, Anthony C Smith, Paul A Scuffham
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 6, 2013
Exploring the validity of HPQ-based presenteeism measures to estimate productivity losses in the health and education sectorsPaul A Scuffham, Nerina Vecchio, Harvey A Whiteford
Pageof 21

Showing results (11-20 of 208) with videos related to

Sort By:
Pageof 21
Expert Review of Pharmacoeconomics & Outcomes Research|May 1, 2009
Pharmacoeconomic benefits of dasatinib in the treatment of imatinib-resistant patients with chronic myelogenous leukemiaMatthew J Taylor, Paul A Scuffham
Pharmacoeconomics|February 26, 2018
The Australian Managed Entry Scheme: Are We Getting it Right?Haitham W Tuffaha, Paul A Scuffham
International Journal of Technology Assessment in Health Care|March 5, 2024
The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancerSrinivas Teppala, Paul A Scuffham, Haitham Tuffaha
Australian Health Review : a Publication of the Australian Hospital Association|September 25, 2018
Simulation of health care and related costs in people with dementia in AustraliaLachlan Standfield, Tracy Comans, Paul A Scuffham
The Lancet. Infectious Diseases|November 11, 2008
Funding of drugs: do vaccines warrant a different approach?Philippe Beutels, Paul A Scuffham, C Raina MacIntyre
Maternal and Child Health Journal|March 16, 2016
Contactable Non-responders Show Different Characteristics Compared to Lost to Follow-Up Participants: Insights from an Australian Longitudinal Birth Cohort StudyShu-Kay Ng, Rani Scott, Paul A Scuffham
The Medical Journal of Australia|February 3, 2017
Setting Medical Research Future Fund priorities: assessing the value of researchHaitham W Tuffaha, Lazaros Andronis, Paul A Scuffham
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Comment on the use of vignettes and the EQ-5D to value disease-specific health statesSanjeewa Kularatna, Jennifer A Whitty, Paul A Scuffham
BMC Health Services Research|May 23, 2008
An economic analysis of email-based telemedicine: a cost minimisation study of two service modelsLiam Caffery, Anthony C Smith, Paul A Scuffham
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 6, 2013
Exploring the validity of HPQ-based presenteeism measures to estimate productivity losses in the health and education sectorsPaul A Scuffham, Nerina Vecchio, Harvey A Whiteford
Pageof 21